MTOR inhibitors are effective in the growth inhibition of BLCA cell lines in general, but no distinct subtype-specific inhibitory effect was observed in this study [45,46], which is in line with other subtype-specific studies with mTOR inhibitors [47]. This evidence concerns the gene MTOR and bladder transitional cell carcinoma.